Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for CASI Pharmaceuticals Inc. (CASI : NSDQ)

• Company Description    CASI Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on the acquisition, development and commercialization of proprietary therapeutics for the treatment of cancer and other diseases for the global markets, with a focus on China. The Company's products present antiangiogenic solutions to cancer, cardiovascular disease, and macular degeneration. CASI Pharmaceuticals Inc., formerly known as EntreMed, Inc., is headquartered in Rockville, Maryland. Number of Employees: 233

• Price / Volume Information    Yesterday's Closing Price: $0.85 Daily Weekly Monthly 20 Day Moving Average: 29,817 shares Shares Outstanding: 12.30 (millions) Market Capitalization: $10.45 (millions) Beta: 0.85 52 Week High: $3.29 52 Week Low: $0.75 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -13.11% -12.97% 12 Week -58.54% -59.21% Year To Date 0.00% 0.00%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1701-1702 China Central Office Tower 1 No. 81 Jianguo Road Chaoyang District - Beijing,F4 100025 CHN ph: 86-10-6508-6063 fax: 301-315-2437 ir@casipharmaceuticals.com http://www.casipharmaceuticals.com

• General Corporate Information    Officers Wei-Wu He - Chief Executive Officer and Chairman of the board Chunhua Wang - Chief Operation Officer Daniel Lang - Chief Financial Officer Wei (Larry) Zhang - Senior Vice President Y. Alexander Wu - Director Peer Information CASI Pharmaceuticals Inc. (GSAC) CASI Pharmaceuticals Inc. (CASI) CASI Pharmaceuticals Inc. (ALCD.) CASI Pharmaceuticals Inc. (OMNN) CASI Pharmaceuticals Inc. (CGPI.) CASI Pharmaceuticals Inc. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: G1933S101 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 03/30/26 Share - Related Items Shares Outstanding: 12.30 Most Recent Split Date: 6.00 (0.10:1) Beta: 0.85 Market Capitalization: $10.45 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.36 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.41 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 03/30/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.39 EPS Growth vs. Year Ago Period: -21.82% vs. Previous Quarter: 22.09% Sales Growth vs. Year Ago Period: -60.54% vs. Previous Quarter: -26.35% ROE 12/31/25 - - 09/30/25 - - 06/30/25 - - ROA 12/31/25 - - 09/30/25 - -131.54 06/30/25 - -99.07 Current Ratio 12/31/25 - - 09/30/25 - 0.30 06/30/25 - 0.48 Quick Ratio 12/31/25 - - 09/30/25 - 0.24 06/30/25 - 0.39 Operating Margin 12/31/25 - - 09/30/25 - -183.93 06/30/25 - -148.55 Net Margin 12/31/25 - - 09/30/25 - -183.93 06/30/25 - -148.55 Pre-Tax Margin 12/31/25 - - 09/30/25 - -175.56 06/30/25 - -137.90 Book Value 12/31/25 - - 09/30/25 - -2.32 06/30/25 - -1.65 Inventory Turnover 12/31/25 - - 09/30/25 - 4.47 06/30/25 - 2.89 Debt-to-Equity 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Capital 12/31/25 - - 09/30/25 - - 06/30/25 - -

Powered by Zacks Investment Research ©